A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : STEMI / ST-segment elevation MI

[Related PubMed/MEDLINE]
Total Number of Papers: 246
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   STEMI  (>> Co-occurring Abbreviation)
Long Form:   ST-segment elevation MI
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Evaluating the Impact of COVID-19 on a Regional Primary Percutaneous Coronary Intervention Service During the First Wave of COVID-19. PPCI
2022 Impact of SARS-CoV-2 Outbreak on Emergency Department Presentation and Prognosis of Patients with Acute Myocardial Infarction: A Systematic Review and Updated Meta-Analysis. LVEF, NSTEMI
2022 Premature acute coronary syndrome: understanding the early onset. ACS, KK, LVEF
2022 Risk Assessment after ST-Segment Elevation Myocardial Infarction: Can Biomarkers Improve the Performance of Clinical Variables? CT-IGFBP4, CV, eGFR, GDF15, hs-cTnT, MACE
2022 Ten-Year Trends in Patient Characteristics, Treatments, and Outcomes in Myocardial Infarction From National Cardiovascular Data Registry Chest Pain-MI Registry. MI, NSTEMI
2022 The prognostic role of intra-aortic pulse pressure measured before percutaneous coronary intervention in patients with chronic coronary syndrome: a single-center, retrospective, observational cohort study. CCS, DBP, IAPP, LVEF, MACE, PCI, SBP, TVR
2022 Trends and Outcomes of Myocardial Infarction in Patients With Previous Coronary Artery Bypass Surgery. CABG, CI, MI, NSTEMI, OR
2022 [An update on some atypical electrocardiographic forms of acute coronary syndrome The "STEMI equivalents"]. ---
2021 Activation of RAGE-dependent endoplasmic reticulum stress associates with exacerbated postmyocardial infarction ventricular arrhythmias in diabetes. AGEs, CaN, ER, GRP78, MI, PERK, PVCs, RAGE, RAGE, RyR2, VAs
10  2021 Association between new-onset right bundle branch block and primary or secondary ventricular fibrillation in ST-segment elevation myocardial infarction. CI, MI, PVF, RBBB, SVF, VF
11  2021 Association between smoking status and outcomes in myocardial infarction patients undergoing percutaneous coronary intervention. AMI, NSTEMI, PCI
12  2021 Homozygosity of the TT methylenetetrahydrofolate reductase C677T genotype is an independent long-term predictor of cardiac death in patients with premature myocardial infarction. CAD, CI, HR, MI, MTHFR
13  2021 Integrated Gene Expression Profiling Analysis Reveals Potential Molecular Mechanisms and Candidate Biomarkers for Early Risk Stratification and Prediction of STEMI and Post-STEMI Heart Failure Patients. DEGs, GO, LASSO
14  2021 Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic. COVID-19, MI
15  2021 Left Ventricular Remodeling Risk Predicted by Two-Dimensional Speckle Tracking Echocardiography in Acute Myocardial Infarction Patients with Midrange or Preserved Ejection Fraction in Western Romania. AMI, AUC, CAD, EF, LV, PCI, SR
16  2021 Management of left ventricular thrombus: a narrative review. AF, CMR, ECAs, EF, LV, LVEF, LVT, MI, VKA
17  2021 Neutrophil-Derived Protein S100A8/A9 Alters the Platelet Proteome in Acute Myocardial Infarction and Is Associated With Changes in Platelet Reactivity. MI
18  2021 Plasma apelin level in acute myocardial infarction and its relation with prognosis: A prospective study. EF, NSTEMI
19  2021 Primary percutaneous coronary intervention is appropriate in transient ST-elevation myocardial infarction. fSTR, IRA, MI, PPCI, TSTEMI
20  2021 Prognosis of Patients With Left Circumflex Artery Acute Myocardial Infarction in Relation to ST-Segment on Admission Electrocardiogram. ACS, CI, LCX, MI, NSTEMI, OR, PCI
21  2021 Prognostic value of cardiac inflammation in ST-segment elevation myocardial infarction: A 18F-fluorodeoxyglucose PET/CT study. FDG, MACE, MI, PCAT, PET/CT
22  2021 Relation of a novel fibrosis marker and post-myocardial infarction left ventricular ejection fraction in revascularized patients. LVEF, MI
23  2021 Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy. COVID-19, IRR, IRR, IRs, MI
24  2021 Revascularization Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock: Results from the Portuguese Registry on Acute Coronary Syndromes. CS, MI, MVD, ProACS
25  2021 Risk Assessment of Patients After ST-Segment Elevation Myocardial Infarction by Killip Classification: An Institutional Experience. BMI, MI
26  2021 ST-segment elevation myocardial infarction with non-obstructive coronary arteries: Score derivation for prediction based on a large national registry. PPCI
27  2021 Trends in conventional cardiovascular risk factors and myocardial infarction subtypes among young Chinese men with a first acute myocardial infarction. AMI, CI, NSTEMI, OR, RFs
28  2021 Undiagnosed SARS-CoV-2 infection and outcome in patients with acute MI and no COVID-19 symptoms. MI
29  2020 Acute and chronic effects of high-intensity interval and moderate-intensity continuous exercise on heart rate and its variability after recent myocardial infarction: A randomized controlled trial. HIIT, HR, HRV, MI, MICE
30  2020 Acute Coronary Syndrome: Presentation and Diagnostic Evaluation. ACS, CAD, ECG, ED, MI, TIMI
31  2020 Antithrombotic management and long-term outcomes following percutaneous coronary intervention for acute coronary syndrome in Asia. ACS, AMPs, DAPT, MACE, MI, NSTEMI, PCI, UA
32  2020 Associations of changes in patient characteristics and management with decrease in mortality rates of men and women with ST-elevation myocardial infarction - a propensity score-matched analysis. ---
33  2020 Double or Triple Antithrombotic Treatment in Atrial Fibrillation Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention. AF, DAT, MI, OAC, PCI, TAT
34  2020 Effect of COVID-19 on acute treatment of ST-segment elevation and Non-ST-segment elevation acute coronary syndrome in northwestern Switzerland. COVID-19, CPO, ED, LVEF, NSTE-ACS, PCIs
35  2020 Effect of Oral N-Acetylcysteine Supplementation on the Immunity System in Patients with Acute Myocardial Infarction. AMI, CRP, Gal-3, hs-CRP, MPO, NAC
36  2020 Evaluation of pharmacoinvasive strategy versus percutaneous coronary intervention in patients with acute myocardial infarction with ST segment elevation at the National Institute of Cardiology (PHASE-MX). PCI
37  2020 Evaluation of pharmacoinvasive strategy versus percutaneous coronary intervention in patients with acute myocardial infarction with ST-segment elevation at the National Institute of Cardiology (PHASE-MX). PCI
38  2020 Follow-Up After Myocardial Infarction toExplore the Stability of Arrhythmogenic Substrate: The Footprint Study. AMI, BZ, BZCs, LGE-CMR
39  2020 Impact of clinical presentations on lipid core plaque assessed by near-infrared spectroscopy intravascular ultrasound. ACS, CCS, LCP, maxLCBI4mm, MI, NIRS-IVUS, NSTEMI, UA
40  2020 Impact of concurrent right ventricular myocardial infarction on outcomes among patients with left ventricular myocardial infarction. LVMI, PCI, RVMI
41  2020 Impact of medicaid expansion on disparities in revascularization in patients hospitalized with acute myocardial infarction. NSTEMI
42  2020 Is There a Sex Gap in Surviving an Acute Coronary Syndrome or Subsequent Development of Heart Failure? MI, NSTEMI
43  2020 Poor recovery of cardiac function in myocardial infarction patients with metabolic syndrome and microalbuminuria. AMI, LVEF, MetS, NT-proBNP
44  2020 Presence of bacterial DNA in thrombotic material of patients with myocardial infarction. ACS, AMI, PCR, PPCI
45  2020 Status of Acute Myocardial Infarction in Southern India During COVID-19 Lockdown: A Multicentric Study. COVID-19, MI, NSTEMI
46  2020 The FAST-STEMI Network in Biella From 2013 to 2019: Impact of the Delocalization of the Hospital Facilities on Ischemia Time and In-hospital Outcomes. CI, EF, HR, PE, PTB
47  2020 The Genetic Variants -717T>C (rs2794521), 1444G>A (rs1130864), and 1846 C > T (rs1205) of CRP Gene, Their Haplotypes, and Their Association with Serum CRP Levels, Acute Coronary Syndrome, and Diabetes in Patients from Western Mexico. ACS, CG, CRP, hs-CRP, OR, T2DM, UA
48  2020 [Myocardial Infarction in Women of Reproductive age: Risk Factors, Clinical Picture, Prognosis]. AH, CV, MACE, NSTEMI, RF
49  2019 Acute and 1-Year Hospitalization Costs for Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention: ResultsFrom the TRANSLATE-ACS Registry. MI
50  2019 Acute myocardial infarction in the young - National Trend Analysis with gender-based difference in outcomes. AMI, NIS, NSTEMI
51  2019 Differences in symptoms and pre-hospital delay among acute myocardial infarction patients according to ST-segment elevation on electrocardiogram: an analysis of China Acute Myocardial Infarction (CAMI) registry. AMI, CAMI, NSTEMI
52  2019 Do Patients need Lifelong beta-Blockers after an Uncomplicated Myocardial Infarction? ESC, MI
53  2019 Rationale and Design of the High Platelet Inhibition with Ticagrelor to Improve Left Ventricular Remodeling in Patients with ST-Segment Elevation Myocardial Infarction (HEALING-AMI) Trial. LV, MI, NT-proBNP
54  2019 Serum Soluble ST2 and Adverse Left Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction. AUC, CI, LVR, MI, NT-proBNP, PCI, sST2
55  2019 [More equity in Lazio region health care: results from the Regional Outcome Evaluation Program (PReValE), 2012-2017]. MOR
56  2018 Acute coronary syndromes in patients with active hematologic malignancies - Incidence, management, and outcomes. ACS, NSTEMI, UA
57  2018 Air pollution in relation to very short-term risk of ST-segment elevation myocardial infarction: Case-crossover analysis of SWEDEHEART. MI, OR
58  2018 Characteristics of patients presenting with myocardial infarction with non-obstructive coronary arteries (MINOCA) in Poland: data from the ORPKI national registry. CAD, MI, MINOCA, NSTEMI
59  2018 Copeptin as a prognostic biomarker in acute myocardial infarction. MI
60  2018 Coronary Artery Thromboses, Stent Thrombosis and Antiphospholipid Antibody Syndrome: Case Report. AMI, CAD
61  2018 Correlation between Changes in Local Earth's Magnetic Field and Cases of Acute Myocardial Infarction. LUHS
62  2018 Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction? MI
63  2018 Frailty and Outcomes After Myocardial Infarction: Insights From the CONCORDANCE Registry. FI, MI, NSTEMI
64  2018 Impact of metabolic syndrome on clinical severity and long-term prognosis in patients with myocardial infarction with ST-segment elevation. MACE, MetS
65  2018 Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI. AMI, CD, CI, DES, HR, MACE, NSTEMI, PCI, PSM, RASi, re-MI, TLR, TVR
66  2018 Long-Term Outcome of Acute Coronary Syndromes in Patients on Chronic Oral Anticoagulants: Data from the EPICOR Study. ACS, NSTEACS, OAC, OACb, PCI, TIMI
67  2018 Longterm survival of elderly patients after myocardial infarction depending on management in the acute period of the disease. ---
68  2018 MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy. MI, MR-proADM
69  2018 Predictive value of metabolic syndrome definitions in patients with myocardial infarction with ST segment elevation - are they all the same? MS
70  2018 Recurrent Cardiovascular Events in Survivors of Myocardial Infarction With ST-Segment Elevation (from the AMI-QUEBEC Study). PCI, RICEs, TIMI
71  2018 Safety of early discharge in low risk patients after acute ST-segment elevation myocardial infarction, treated with primary percutaneous coronary intervention. Open label, randomized trial. MI, PCI
72  2018 Survival benefit from recent changes in management of men and women with ST-segment elevation myocardial infarction treated with percutaneous coronary interventions. PCI, PL-ACS
73  2018 The influence of the manual thrombus aspiration on the short term effectiveness of the percutaneous revascularization in patients with coronary artery thrombosis. CG, MG, PCI
74  2018 TIMI and GRACE Risk Scores Predict Both Short-Term and Long-Term Outcomes in Chinese Patients with Acute Myocardial Infarction. GRACE, MI, NSTEMI, RSs, TIMI
75  2017 Characteristics, in-hospital management and outcome of late acute ST-elevation myocardial infarction presenters. ICCU, OR
76  2017 Concomitant pulmonary embolism and myocardial infarction due to paradoxical embolism across a patent foramen ovale: a case report. MI, PE, RV
77  2017 Contemporary Risk Stratification After Myocardial Infarction in the Community: Performance of Scores and Incremental Value of Soluble Suppression of Tumorigenicity-2. MI, NSTEMI, TIMI
78  2017 Diagnostic value of copeptin in acute myocardial infarction. AMI, NSTEMI
79  2017 Effect of Chronic Obstructive Pulmonary Disease on In-Hospital Mortality and Clinical Outcomes After ST-Segment Elevation Myocardial Infarction. aOR, COPD
80  2017 Factors associated with advanced cardiac care in prehospital chest pain patients. EMS
81  2017 Increased complements and high-sensitivity C-reactive protein predict heart failure in acute myocardial infarction. AMI, hs-CRP, NSTEMI
82  2017 Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. DES, MI, NNT, NSTEMI, UA, WIN-DES
83  2017 Management and Outcomes of ST-Segment Elevation Myocardial Infarction in US Renal Transplant Recipients. aOR, MI
84  2017 Mechanistic Role of mPTP in Ischemia-Reperfusion Injury. IS, MI, mPTP, PCI, RI
85  2017 Myocardium at risk assessed by electrocardiographic scores and cardiovascular magnetic resonance - a MITOCARE substudy. AL, CMR, MaR, MI, VH
86  2017 Outcomes in elderly and young patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with bivalirudin versus heparin: Pooled analysis from the EUROMAX and HORIZONS-AMI trials. NACE, PPCI
87  2017 Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry. AMI, CI, NSTEMI, PCI, TIMI
88  2017 Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction. DPP4, DPP4a, MACCE, MI
89  2017 Prothrombotic genetic risk factors in patients with very early ST-segment elevation myocardial infarction. APS, MI, OR
90  2017 Surgical Revascularisation in the Early Phase of ST-Segment Elevation Myocardial Infarction: Haemodynamic Status is More Important Than the Timing of the Operation. CABG, IABC
91  2017 Temporal trends in acute myocardial infarction presentation and association with use of cardioprotective drugs: a nationwide registry-based study. CI, CI 0.78-0.87, MI, NSTEMI, OR
92  2016 Acute Coronary Syndrome with ST-segment Elevation in Pregnancy: Anesthetic Management of Delivery. ACS, MI
93  2016 Acute myocardial infarction due to left main coronary artery disease in men and women: does ST-segment elevation matter? NSTEMI, PCI, ULMCA
94  2016 Aspiration thrombectomy prior to percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis. AT, PCI, RCTs, RD, RR
95  2016 Association diastolic function by echo and infarct size by magnetic resonance imaging after STEMI. CMR, LV, MI
96  2016 Coronary angiography after successful thrombolysis - Is the recommended time interval of 24h an important issue? PCI
97  2016 Depression and Anxiety after Acute Myocardial Infarction Treated by Primary PCI. PPCI
98  2016 Diabetic Patients with an Acute Myocardial Infarction in Terms of Risk Factors and Comorbidities Management: Characteristics of the Highest-Risk Individuals. AMI, DM, LMD, NSTEMI
99  2016 Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease. MI
100  2016 Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial. LDL, LVEF, MI